Clinical trials
Phase 1 Critical Illness trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 3 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 2 |
| McMaster University | 2 |
| A.P.J. Vlaar | 1 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Denver Health and Hospital Authority | 1 |
| Dr Elizabeth Papathanassoglou | 1 |
| Duke University | 1 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 1 |
| Hospital Regional Dr. Rafael Estévez | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Critical Illness | 20 |
| Sepsis | 5 |
| Pneumonia | 3 |
| COVID-19 | 2 |
| Cellulitis | 1 |
| Cross Infection | 1 |
| Delirium | 1 |
| Infections | 1 |
| Inflammation | 1 |
| Multiple Organ Failure | 1 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.